Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
- PMID: 33195997
- PMCID: PMC7652409
- DOI: 10.1007/s42399-020-00634-0
Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
Abstract
New data specific to COVID-19 are emerging quickly on key issues of immunity and prevention, but past research in coronavirology and for other human pathogens (e.g., Mycoplasma pneumoniae) has been available and of great relevance. Considerable study of endemic human coronaviruses has shown that neutralizing antibody correlates with protection, but effective clinical protection is variable for subsequent virus exposure. Animal coronavirus research has emphasized the importance of local mucosal protection (especially IgA) and systemic responses. Animal model and human post-infection studies for SARS-CoV and MERS-CoV are largely corroborative. Whether for passive therapeutic strategies or vaccination, these findings provide a template for COVID-19. Many approaches to vaccination have emerged, and there may be more than one vaccine that will be applied, but individualized obstacles and concerns for administration, efficacy, and safety are inevitable. Regardless of safeguards or promises that may be understood from laboratory or vertebrate experiments, observations from large-scale human trials will ultimately prove to shape the medical future. Focus on common mucosal immunity can be underrated, and equally or more, focus on lactogenic immunity may be underestimated. In understanding both passive immunity and protection, the body is already primed to educate us with decisions of what constitutes protection and harm. This review provides key insights that drive hypotheses into how the instinct of immunity and the intelligence of the maternal component of the common mucosal immune system has already guided us and may continue to do so effectively into a bright and safe future.
Keywords: Coronavirus; Immunity; Infection; Lactation; Mucosa.
© Springer Nature Switzerland AG 2020.
Conflict of interest statement
Conflict of InterestThe author declares that he has no conflict of interest.
Similar articles
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490. Elife. 2022. PMID: 35072628 Free PMC article.
-
Stage of Gestation at Porcine Epidemic Diarrhea Virus Infection of Pregnant Swine Impacts Maternal Immunity and Lactogenic Immune Protection of Neonatal Suckling Piglets.Front Immunol. 2019 Apr 24;10:727. doi: 10.3389/fimmu.2019.00727. eCollection 2019. Front Immunol. 2019. PMID: 31068924 Free PMC article.
-
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.Curr Opin Infect Dis. 2021 Jun 1;34(3):181-186. doi: 10.1097/QCO.0000000000000724. Curr Opin Infect Dis. 2021. PMID: 33899752 Review.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
Cited by
-
Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.SN Compr Clin Med. 2021;3(10):2093-2108. doi: 10.1007/s42399-021-00992-3. Epub 2021 Jun 22. SN Compr Clin Med. 2021. PMID: 34179695 Free PMC article. Review.
-
In pursuit of the right tail for the COVID-19 incubation period.Public Health. 2021 May;194:149-155. doi: 10.1016/j.puhe.2021.03.011. Epub 2021 Mar 26. Public Health. 2021. PMID: 33915459 Free PMC article. Review.
-
Bibliometric Analysis of the Publications on Middle East Respiratory Syndrome Coronavirus Published Between 2012-2022.Infect Dis Clin Microbiol. 2023 Sep 30;5(3):221-230. doi: 10.36519/idcm.2023.244. eCollection 2023 Sep. Infect Dis Clin Microbiol. 2023. PMID: 38633555 Free PMC article.
-
Immunophenotyping of SARS-CoV-2 and vaccine design.Vaccine. 2022 Jun 26;40(30):3985-3986. doi: 10.1016/j.vaccine.2022.04.071. Vaccine. 2022. PMID: 35717108 Free PMC article. No abstract available.
-
COVID-19 among infants: key clinical features and remaining controversies.Clin Exp Pediatr. 2024 Jan;67(1):1-16. doi: 10.3345/cep.2023.00794. Epub 2023 Nov 27. Clin Exp Pediatr. 2024. PMID: 38013408 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous